Familial forms of genitourinary cancers: clinical and genetic aspects;Formes familiales des cancers de l'appareil urogénital: Aspects cliniques et génétiques

Progres en Urologie

Volumn 6, Issue 3, 1996, Pages 343-355

  Fournier, Georges ^a,c   Valeri, Antoine ^a   Cussenot, Olivier ^b  

^a CHU MORVAN   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Detection; Genetic; Genetic counselling; Heredity; Urogenital cancer

Indexed keywords

GENETICS; HUMAN; KIDNEY TUMOR; MALE; PROSTATE TUMOR; REVIEW; TESTIS TUMOR; UROGENITAL TRACT TUMOR;

HUMANS; KIDNEY NEOPLASMS; MALE; PROSTATIC NEOPLASMS; TESTICULAR NEOPLASMS; UROGENITAL NEOPLASMS;

EID: 0030167304     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. ANDERSON D E., BADZIOCH M.D., Familial breast cancer risks. Effects of prostate and other cancers. Cancer, 1993, 72, 114-119.
2. APRIKIAN A., BAZINET M., PLANTE M., et al. Family history and the risk of prostatic carcinoma in a high risk group of urological patients. J. Urol. 1995, 154, 404-406.
3. BASTACKY S., WOJNO K., WALSH P., CARMICHAEL M., EPSTEIN J. Pathological features of hereditary prostate cancer. J. Urol., 1995, 153, 987-992.
4. BERGERHEIM U.S.R., KUNIMI K., COLLINS P., EKMAN P. Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma. Genes, Chromosomes, & Cancer, 1991, 3, 215-220.
5. BOVA G.S., CARTER B S , BUSSEMAKERS M.J.B., EMI M., FUJIWARA Y., KYPRIANOU N., et al. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 1993, 53, 3869-3873.
6. BRESLOW N., OLSHAN A., BECKWITH J.B., GREEN D.M. Epidemiology of Wilms' tumor. Med. Pediatr. Oncol., 1993, 21, 172-181.
7. BRESSAC B., GRANDJOUAN S. Prédispositions génétiques aux cancers. Rev. Prat., 1992, 42, 7, 803-810.
8. BREWSTER S F., BROWNE S., BROWN K.W. Somatic allelic loss at the DCC, APC, nm23-H1 and P53 tumor suppressor gene loci in human prostatic carcinoma. J. Urol., 1994, 151, 1073-1077.
9. BURKLAND C.E., JUZEK R.H. Familial occurence of carcinoma of the ureter. J.Urol., 1966, 96, 697-701
10. CAROLL P.R., MURTY V.V.S., REUTER V. et al. Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma. Cancer Genet. Cytogenet., 1987, 26, 253-259.
11. CARTER B.S., EWING C M , WARD W.S et al. Allelic loss of chromosome 16q and 10q in human prostate cancer. Proc Natl Acad. Sci. USA, 1990, 87, 8751-8755.
12. CARTER B.S., BEATY T.H., STEINBERG G.D., CHILDS B., WALSH P.C. Mendelian inheritance of familial prostate cancer Proc. Natl. Acad. Sci. USA. 1992, 89, 3367-3371.
13. CARTER B.S., BOVA G.S., BEATY T.H., STEINBERG G.D., CHILDS B., ISAACS W.B., WALSH P.C. Hereditary prostate cancer: epidemiologic and clinical features. J. Urol., 1993, 150, 797-802.
14. CASTEGNARO M., MARU V., PETKOVA - BOCHAROVA T., et al. Concentrations of ochratoxin A in the urine of endemic nephropathy in patients and controls in Bulgaria: lack of detection of 4 - hydroxyochratoxin A. International Agency for Research on Cancer, 1991, 165-169.
15. CHENG W., FARROW G., ZINCKE H. The incidence of multicentricity in renal cell carcinoma. J.Urol., 1991, 146, 1221-1223.
16. CHRISTENSON P.J., CRAIG J.P., BIBRO M.C., O' CONNELL K.J. Cysts containing renal cell carcinoma in von Hippel-Lindau disease. J.Urol., 1982, 128, 798-800.
17. COHEN A.J., LI F.P., BERG S. Hereditary renal cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med., 1979, 301, 592-595.
18. COHEN-HAGUENAUER O. Mise en place des consultations d'oncogénétique. In Boiron M. et Marty M. eds. Eurocancer 95. John Libbey Eurotext, Paris, Londres, Rome, 1995, pp. 25-27.
19. CONQUY S., Contribution à l'étude des lésions uro-génitales de la maladie de von Hippel-Lindau . Thèse de Doctorat en Médecine, 1982 (Paris).
20. CONQUY S., STEG A., FERRY M., Cancer du rein bilatéral chez une patiente atteinte d'une maladie de von Hippel-Lindau . Ann. Urol., 1987,21,5,350-352.
21. COOPER M., FELLOWS J., EINHORN LH. Familial occurence of testicular cancer. J.Urol., 1994, 151, 1022-1023.
22. COPPES J., HABER D., GRUNDY P. Genetic events in the development of Wilms tumor. N.Eng. J. Med., 1994, 331, 586-590.
23. COUL.ANGE C. Enquête épidémiologique des tumeurs du rein. In Synthèse et recommandations en onco-urologie, Monogr. N° 2, Pros. Urol., Novembre 1993, Abbou C.C. et Lobel B. ed. pp 200-201.
24. CUKURANOVIC R., IGNJATOVIC M, STEFANOVIC V. Urinary tract tumors and Balkan nephropathy in the South Morava River basin. Kidney Int , 1991 ,40,34 (suppl.), 80-84.
25. DOUKETIS J,. BURKES R.L . Familial testicular cancer . What role does heredity play ? Canadian Family Physician, 1993, 39, 1640-1641.
26. EAGLE L.R , YIN X., BROTHMAN A.R., WILLIAMS B.J., ATKIN N B., PROCHOWNIK E.V. Mutation of the MXI gene in prostate cancer. Nature Genetics, 1995, 9, 249-255.
27. ENG C., PONDER B.A.J. The role of gene mutations in the genesis of familial cancers. Faseb J., 1993, 7, 910-919.
28. FETNER C., BARILLA D., SCOTT T., et al. Bilateral renal cell carcinoma in Von Hippel-Lindau syndrome. Treatment with staged bilateral nephrectomy and hemodialysis J Urol., 1977, 117, 534-536.
29. FINAN M.C., CONNOLLY S.M. Sebaceous gland tumors and systemic disease: a clinico-pathologic analysis. Medicine, 1984, 63, 4, 232-242
30. FORMAN D., OLIVER R., BRETT A.., MARSH S., MOSES J., BODMER J., et al. Familial testicular cancer: a report of the U.K. family register, estimation of risk and an HLA Class 1 sib-pair analysis. Br J. Cancer, 1992, 65, 255-262.
31. FOURNIER G., LATIL A., AMET Y, .et al. Gene amplification in advanced-stage human prostate cancer. Urol.Res., 1995, 22, 343-348.
32. FRAUMENI J.F. THOMAS L.B., Malignant bladder tumors in a man and his three sons. J.A.M.A., 1967, 201,97-99.
33. GAO X., ZACHAREK A., SALKOWSKI A., et al. Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res., 1995, 55, 1002-1005.
34. GAUTIER J.F., SCHLUMBERGER M., FONSECA E. et al . Phéochromocytome familial et maladie de von Hippel-Lindau. Presse Med., 1990, 19,32, 1494-1496.
35. GLENN G.M., LINEHAN WM., HOSOE S., ZBAR B. Screening for von Hippel-Lindau disease by DNA polymolphism analysis. J.A.M.A., 1992, 267, 1226-1231.
36. GLOVER T.W., COYLE - MORRIS J.F. LI F.P. et al. Translocation t(3 :8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14 (FRA3B) in lymphocytes. Cancer Genet. Cytogenet., 1988, 31,69-73.
37. GNARRA J.R ., GLENN G.M., LATIF F. et al . Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol. Clin. North Am., 1993, 20, 207-216.
38. GO R.C., LAMIELL J.M., HSIA Y.E. et al . Segregation and linkage analysis of Von Hippel-Lindau disease among 220 descendants from one kindred. Am. J. Hum. Genet., 1984, 36, 131-142.
39. GRANDJOUAN S. Conseil génétique en cancérologie. Les cancers du colon. Path.Biol., 1994, 42, 107-108.
40. GREENLAND J.E., WESTON M.T., WALLACE M.A. Familial transitional cell carcinoma and the Lynch syndrome II. Brit. J. Urol., 1993, 72, 177-180.
41. GRIGNON D.J., SHUM D.T., BRUCKSCHWAIGER O. Transitional cell carcinoma in the Muir-Torre syndrome. J. Urof., 1987, 138, 406-408.
42. GRUNDY P., KOUFOS A., MORGAN K., LI F.P. et al. Familial predisposition to Wilms' tumor does not map to the short arm of chromosome 11. Nature, 1988, 336, 374-376.
43. HOSOE S., BRAUCH H., LATIF F. et al. Localization of the Von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics, 1990, 8, 634-640.
44. HUFF V., COMPTON D.A., CHAO L.Y. et al . Lack of linkage of familial Wilms' tumour to chromosomal band 11p13. Nature, 1988, 336, 377-378.
45. KANTOR A F., HARTGE P., HOOVER R.N. et al. Familial and environmental interactions in bladder cancer risk. Int. J. Cancer., 1985, 35, 703-706.
46. KEELER L.L ., KLAUBER G.T., Von Hippel - Lindau disease and renal cell carcinoma in a 16-year-old boy. J. Urol., 1992, 147, 1588-1591.
47. KING M C. Genetic analysis of cancer in families. Cancer Surveys, 1990, 9, 417-435.
48. KNUDSON A.C. Retinoblastoma: a prototype hereditary neoplasm. Semin. Oncol., 1978, 5, 57-60.
49. KNUDSON A.G Antioncogenes and human cancer. Proc.Natl.Acad.Sci.USA, 1993, 90, 10914-10921
50. KOO H., HENSLE T. Molecular biology of Wilms' tumor. Urol.Clin.North.Am., 1993, 20, 323-331.
51. KOVACS G., ERLANDSSON R., BOLDOG F. et al. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc. Natl. Acad. Sci. USA, 1988, 85, 1571-1575.
52. KOVACS G. Papillary renal cell carcinoma. Am. J. Pathol., 1989, 134, 27-34.
53. KRAMER A.A ., GRAHAM S., BURNETT W.S. et al. Familial aggregation of bladder cancer stratified by smoking status. Epidemiology, 1991, 2, 145-148.
54. LABERGE J.M., NGUYEN L.T., HOMSY Y.L., DOODY D.P., Bilateral Wilms' tumors: changes concepts in management. J. Ped. Surg., 1987, 22, 730-735.
55. LAMIELL J.M., SALAZAR F.G., HSL I.A.E. Von Hippel-Lindau disease - Affecting 43 members of a single kindred. Medicine, 1989, 68, 1-29.
56. LATIF F., TORY K., GNARRA J. et al. Identification of the Von Hippel-Lindau disease tumor suppressor gene. Science, 1993, 260, 1317-1320
57. LATIL A., BARON J.C., CUSSENOT O. et al. Genetic alterations in localized prostate cancer : identification of a common region of deletion on chromosome arm 18q. Genes. Chromos. & Cancer, 1994, 11, 119-125.
58. LATIL A., CUSSENOT O., FOURNIER G., BARON J.C., LIDEREAU R. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. Clin. Cancer Res., 1995, 1385-1389.
59. LEAHY M., TONKS S., MOSES J. et al. Candidate regions for a testicular cancer susceptibility gene. Hum. Mol. Genet., 1995, 4, 1551-1555.
60. LEMERLE J., TOURNADE M.F. Nephroblastome (tumeur de Wilms). Rev. Prat. (Paris), 1993, 43, 2592-2196.
61. LEVLNE E., WEIGEL J., COLLINS D Diagnosis and management of asymptomatic renal cell carcinomas in Von Hippel-Lindau syndrome. Urology, 1983, 21, 146-50.
62. LINDBLOM A., TANNERGARD P., WERELIUS B. et al. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genetics, 1993, 5 , 279-82.
63. LOEB L. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res., 1991, 51, 3075-3079.
64. LOUGHLIN K.R , GITTES R.F. Urological management of patients with Von Hippel-Lindau disease. J. Urol , 1986, 136, 789-791.
65. LYNCH H.T., WALZAK M.P., FRIED R. et al. Familial factors in bladder carcinoma. J.Urol., 1979, 122, 458-461.
66. LYNCH H.T., KIMBERLLNG W.J., LYNCH J.F. et al. Familial bladder cancer in an oncology clinic Cancer Genet. Cytogenet., 1987, 27, 161-165.
67. LYNCH H.T., ENS J.A., LYNCH J.F. The Lynch syndrome II and urological malignancies. J. Urol., 1990, 143, 24-28.
68. LYNCH H.T., RICHARDSON J.D., AMIN M. et al. Variable gastrointestinal and urologic cancers in a Lynch syndrome II kindred. Dis.Colon Rectum 1991, 34 ,891-895.
69. MC CULLOUGH D.L., LAMM D.L., MC LAUGHLIN A.P. et al. Familial transitional cell carcinoma of the bladder. J. Urol., 1975, 113, 629-635.
70. MC WHORTER W.P., HERNANDEZ A.D., MEIKLE A.W. et al. A screening study of prostate cancer in high risk families. J. Urol., 1992, 148, 826-828.
71. MACOSKA J.A., SAKR W., BENSON P., PONTES I.E. Allelic loss at 8p, 10q and 16q in microdissected prostate tumors. J. Urol., 1993, 149, 221A.
72. MAHBOUBI A.O., AHLVIN R.C., MAHBOUBI E.O. Familial aggregation of urothehal carcinoma. J. Urol., 1981, 126, 691-692.
73. MAHER E., YATES J. Familial renal cell carcinoma , clinical and molecular genetic aspects, Br. J. Cancer, 1991, 63, 176-179.
74. MAHER E. Genetics of urological cancers. Br. Med. Bull., 1994, 50, 698-707.
75. MALEK R.S., OMESS P.J., BENSON R C., ZINCKE H. Renal cell carcinoma in Von Hippel-Lindau syndrome. Am. J. Med., 1987, 82, 236-238.
76. MARCHETTO D., LI F.P., HENSON D.E. Familial carcinoma of ureters and other genitourinary organs. J. Urol., 1983, 130, 772-773.
77. MARKOVIC B Néphropathie des Balkans et carcinome à cellules transitionnelles. J. Urol. (Paris), 1985, 91, 215-220.
78. MATSUNAGA E . Genetics of Wilms' tumor. Hum. Genet., 1981, 57, 231-246.
79. MORGANTI G., GIANFERRARI L., CRESSERI A. et al. Recherches clinico-statistiques et génétiques sur les néoplasies de la prostate. Acta Genetica Statistica, 1956, 6, 304-305.
80. MUIR E.G., YATES - BELL A.J . BARLOW KA . Multiple primary carcinoma of the colon, duodenum and larynx associated with keratoacanthoma of the face. Br. J. Surg., 1967, 54,191-195.
81. MUKAMEL E., KONICHEZKY M., ENGELSTELN D , SERVADIO C. Incidental small renal tumors accompanying over renal cell carcinoma. J. Urol., 1988, 140, 22-24.
82. NARITA H., KANSAKI T., YOKOTA M. et al. Muir-Torre syndrome. J. Dermatol., 1992, 19,105-108.
83. NELSON J., OYASU R., DALTON D. The clinical and pathological manifestations of renal tumors in Von Hippel-Lindau disease. J. Urol., 1994, 152, 2221-2226.
84. NICHOLSON P., HARLAND S. Inheritance of testicular cancer. Br. J. Cancer, 1995, 71, 421-426.
85. NOVICK A., STREEM S. Long-term following after nephron sparing surgery for renal cell carcinoma in Von Hippel-Lindau disease. J. Urol., 1992, 147, 1488-1490.
86. NYSTROM-LAHTI M , PARSONS R., SISTONEN P. et al. Mismatch repair genes on chromosome 2p and 3p account for a major share of hereditary non-polyposis colorectal cancer families evaluable by linkage Am. J. Hum. Genet , 1994, 55, 659-665.
87. OLSCHWANG S., THOMAS G. Clonage de quatre gènes de susceptibilité au cancer colique héréditaire sans polypose: mode d'emploi. In Boiron M. et Many M. eds. Eurocancer 95, Paris, Londres, Rome, pp. 51-53.
88. ORPHALI S.L.J., SHOLS G.W., HAGEWOOD J., TESLUK H., PALMER J.M. Familial transitional cell carcinoma of renal pelvis and upper ureter. Urology, 1986, 27, 394-396.
89. PAPADOPOULOS N , NICOLAIDES N., WEI Y. et al. Mutation of a mut L homolog in hereditary colon cancer. Science, 1994, 263, 1625-1629.
90. PEARSON J.C., WEISS J , TANAGHO E.A. A plea for conservation of kidney in renal adenocarcinoma associated with Von Hippel-Lindau disease. J. Urol , 1980, 124, 910-912.
91. PELTOMAKI P., AALTONEN L., SISTONEN P. et al Genetic mapping of a locus predisposing to human colorectal cancer. Science, 1993, 260, 810-812.
92. POSTON C.D., JAFFRE G.S., LUBENSKY I.A. et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with Von Hippel-Lindau disease: Clinical and molecular genetic implications. J Urol., 1995, 153, 22-26.
93. PUNGA-MAOLE M.L.., HUBERT J ., GRIGNON Y., FLOQUET J., MANGIN P. Les tumeurs tubulo-papillaires du rein. Particularités cliniques, histologiques et cytogénétiques A propos de 15 nouvelles observations. Prog. Urol., 1994, 4, 977-986.
94. PURTILO D.T., MC CARTHY B , YANG J.P.S. et al. Familial urinary bladder cancer. Semin. Oncol., 1979, 6, 254-256.
95. RADOVANOVIC Z., KRAJINOVIC S., JANKOVIC S. et al . Family history of cancer among cases of upper urothelial tumours in a Balkan nephropathy area J. Cancer. Res. Clin. Oncol., 1985, 110, 181-183.
96. RADOVANOVIC Z. VELIMIROVIC D., NAUMOVIC T. Upper urothelial tumours and the Balkan nephropathy. Interference from the study of a family pedigree Eur. J. Cancer , 1990, 26, 391-392.
97. RICHARD S., OLSCHWANG S., CHAUVEAU D., RESCHE F. La maladie de Von Hippel-Lindau. Med. Sci., 1995, 11, 43-51.
98. RICHARD S., Peut-on encore ignorer la maladic de Von Hippel-Lindau. In Boiron M et Marty M. eds., Eurocancer 95. John Libbey Eurotext, Paris, Londres, Rome, 1995, pp. 17-18.
99. RUCCIONE K. Wilms' tumor : a paradigm, a parallel and a puzzle. Sem Oncol. Nurs., 1992, 8, 241-251.
100. SANDBERG A.A., BERGER C S., HADDAD F.S. et al. Chromosome change in transitional cell carcinoma of ureter. Cancer Genet. Cytogenet., 1986, 19, 335-340.
101. SCHWARTZ C., HABER D.A., STANTON V.P., STRONG L.C., SKOLNICK M.H., HOUSMAN D.E. Familial predisposition to Wilm's tumor does not segregate with the WT1 gene. Genomics, 1991, 10, 927-930.
102. SCHULTE PA. The role of genetic factors in bladder cancer. Cancer detection and prevention, 1988, 11, 379-388
103. SEIZINGER B.R., ROULEAU G.A., OZELIUS L.J. et al . Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature, 1988, 332, 268-269.
104. SEIZINGER B.R., SMITH D.I., FILLING - KATZE M.R. et al. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel-Lindau disease. Proc. Natl. Acad. Sci. USA, 1991, 88, 2864-2868
105. SHARMA S.K., BAPNA B.C., SINGH S.M. Familial profile of transitional cell carcinoma. Br. J. Urol., 1976, 48, 442.
106. SIDRANSKY D., MESSING E. Molecular genetics and biochemical mechanisms in bladder cancer. Urol. Clin. North. Am ,1992, 19, 629-639.
107. SKOLNICK M., BEAN L.L., DINTELMAN S.M. et al. A computerized family history data system. Sociology and Social Research, 1979, 63, 506-523.
108. SLATER R.M., MANNENS M.A.M. Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet. Cytogenet., 1992, 6, 111-121.
109. SNYDER H.M., D'ANGIO G.J., EVANS A.E., RANEY R.B. Wilms' tumor and other renal tumors of childhood, in Campbell's Urology (Walsh PC, Retik A.B., Stamey TA. et al). WB Saunders Company 1992, 1967-1987. (Philadelphia-London-Toronto).
110. STEINBACH F., NOVICK A., SHOSKES D. Renal transplantation in patients with renal cell carcinoma and Von Hippel-Lindau disease. Urology, 1994, 44, 760-763.
111. STEINBERG G D , CARTER B.S., BEATY T.H., CHILDS B., WALSH P. Family history and the risk of prostate cancer The Prostate, 1990, 17, 337-347.
112. THIESSEN E.U. Concerning a familial association between breast cancer and both proslatic and uterine malignancies. Cancer, 1974, 34, 1102-1107.
113. TOLLERUD D.J., BLATTNER W.A., FRASER M.C. et al. Familial testicular cancer and urogenital developmental anomalies. Cancer, 1985, 55, 1849-1854.
114. TULINIUS H., EGILSSON V. OLAFSDOTTIR H. et al. Risk of prostate, ovarian and endometrial cancer among relatives of women with breast cancer. Brit. Med. J., 1992, 305, 855-857.
115. VALERI A. Etudes des formes familiales des cancers de l'appareil urogénital l cancers gynécologiques exclus). Thèse de medecine, Brest, 1994, 89 pages.
116. VALERI A., BERTHON P., FOURNIER G. et al. Etude PROGENE projet français d'analyse génétique du cancer de la prostate familial: recrutement et analyse. Prog. Urol., 1996, 2, 226-235.
117. VASEN H.F A., DEN HARTOG-JAGER F.C.A., MENKO F.H. Screening for hereditary non- polyposis colorectal cancer: a study of 22 kindreds in the Netherlands. Am. J. Med., 1989, 86, 278-281.
118. WOOLF C.M. An investigation of the familial aspects of carcinoma of the prostate. Cancer, 1960, 13, 739-744 .
119. ZBAR B., TORY K., MERINO M. et al. Hereditary papillary renal cell carcinoma. J. Urol., 1994, 151, 561-566.
120. ZBAR B., GLEEN G., LUBENSKY I. et al. Hereditary papillary renal cell carcinoma : Clinical studies in 10 families. J. Urol., 1995, 153, 907-912.